Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
UnitedHealth
UNH
|
+$307M |
| 3 |
Global Payments
GPN
|
+$302M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$279M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$433M |
| 2 |
Lam Research
LRCX
|
+$373M |
| 3 |
Pfizer
PFE
|
+$354M |
| 4 |
Verizon
VZ
|
+$341M |
| 5 |
EA
Electronic Arts
EA
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Healthcare | 10.69% |
| 3 | Financials | 10.58% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Myriad Genetics
MYGN
$303M
| $4.33M | ﹤0.01% |
270,101
-27,052
| -9% | -$515K |
|
2327
CTS Corp
CTS
$1.79B
| $4.33M | ﹤0.01% |
103,769
-8,885
| -8% | -$383K |
|
2328
Global X Emerging Markets Great Consumer ETF
EMC
$57.5M
| $4.33M | ﹤0.01% |
182,210
-98,793
| -35% | -$2.47M |
|
2329
Olema Pharmaceuticals
OLMA
$920M
| $4.31M | ﹤0.01% |
349,275
+119,910
| +52% | +$1.22M |
|
2330
FirstCash
FCFS
$9.14B
| $4.3M | ﹤0.01% |
42,825
-4,471
| -9% | -$422K |
|
|
LTC
2331
LTC Properties
LTC
$2.1B
| $4.29M | ﹤0.01% |
133,639
-12,873
| -9% | -$425K |
|
2332
iShares MSCI ACWI ETF
ACWI
$33.6B
| $4.29M | ﹤0.01% |
46,463
-44,789
| -49% | -$4.3M |
|
|
PACW
2333
DELISTED
PacWest Bancorp
PACW
| $4.29M | ﹤0.01% |
542,169
+52,056
| +11% | +$434K |
|
2334
Middlesex Water
MSEX
$1.11B
| $4.29M | ﹤0.01% |
64,715
-7,019
| -10% | -$540K |
|
2335
COPT Defense Properties
CDP
$4.23B
| $4.29M | ﹤0.01% |
179,781
+17,272
| +11% | +$437K |
|
|
SVC
2336
Service Properties Trust
SVC
$1.06B
| $4.28M | ﹤0.01% |
111,316
-10,539
| -9% | -$438K |
|
2337
Agilysys
AGYS
$3.25B
| $4.28M | ﹤0.01% |
64,639
-5,359
| -8% | -$372K |
|
2338
Regenxbio
RGNX
$704M
| $4.27M | ﹤0.01% |
259,668
-5,902
| -2% | -$107K |
|
|
AAMI
2339
Acadian Asset Management
AAMI
$3.31B
| $4.27M | ﹤0.01% |
220,326
-15,597
| -7% | -$322K |
|
2340
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.89B
| $4.26M | ﹤0.01% |
65,680
-14,557
| -18% | -$999K |
|
|
VRNT
2341
DELISTED
Verint Systems
VRNT
| $4.26M | ﹤0.01% |
185,237
+4,464
| +2% | +$144K |
|
|
CFLT
2342
DELISTED
Confluent
CFLT
| $4.25M | ﹤0.01% |
143,616
+7,955
| +6% | +$267K |
|
|
RPT
2343
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $4.24M | ﹤0.01% |
401,443
-52,620
| -12% | -$563K |
|
2344
Nuveen Floating Rate Income Fund
JFR
$1.25B
| $4.24M | ﹤0.01% |
516,862
+147,459
| +40% | +$1.19M |
|
2345
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$726M
| $4.24M | ﹤0.01% |
70,498
+28,547
| +68% | +$1.69M |
|
|
EOT
2346
Eaton Vance National Municipal Opportunities Trust
EOT
$274M
| $4.24M | ﹤0.01% |
261,438
+7,667
| +3% | +$129K |
|
2347
Choice Hotels
CHH
$4.71B
| $4.24M | ﹤0.01% |
34,596
-3,962
| -10% | -$498K |
|
|
VTLE
2348
DELISTED
Vital Energy
VTLE
| $4.24M | ﹤0.01% |
76,426
-14,359
| -16% | -$771K |
|
2349
Greenlight Captial
GLRE
$512M
| $4.23M | ﹤0.01% |
394,168
-12,735
| -3% | -$137K |
|
2350
Astrana Health
ASTH
$1.87B
| $4.23M | ﹤0.01% |
137,150
-7,058
| -5% | -$244K |
|
Similar funds
Ameriprise's Q3 2023 Portfolio in Review
As of Q3 2023, Ameriprise held 4,031 positions worth $305B, down 4.5% from $319B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q3 2023 filing shows 127 new, 1,527 increased, 2,081 reduced and 148 closed positions. Its largest new stake was TKO Group: 772,651 shares worth $64.9M. The largest sale was Johnson & Johnson, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2023 buy was TKO Group: 772,651 shares worth $64.9M.
- Ameriprise added most to AT&T in Q3 2023, an estimated $501M increase.
- Ameriprise's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $433M.
- Ameriprise fully exited NiSource Inc. Series A Corporate Units in Q3 2023, selling an estimated $73.8M.
- Ameriprise's ten largest holdings make up 16% of its $305B portfolio in Q3 2023.
- Ameriprise opened 127 new positions and closed 148 in Q3 2023.
- Ameriprise's portfolio value fell 4.5% quarter-over-quarter to $305B.
Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.